Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients
Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of vitamin D3 on severe asthmatic
patients. Vitamin D3 may alter the response of these patients to conventional steroid
therapy, making them more responsive to the latter form of treatment. Patients will be
treated daily with an oral dose (2,000 IU) of vitamin D3 for one month and their clinical and
serological parameters, and immune function, will be evaluated. Results from pre- and
post-vitaminD3 treatment will be compared.
Phase:
Phase 2
Details
Lead Sponsor:
Florida Atlantic University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins